Familial Clinical Heterogeneity of Medullary Thyroid Cancer with Germline RET S891A Protooncogene Mutation: 7-Year Follow-up with Successful Sorafenib Treatment.


Kizilcan Cetin S., Siklar Z., Ozsu E., Ceran A., Ceyhan K., Aycan Z., ...Daha Fazla

Journal of clinical research in pediatric endocrinology, 2023 (SCI-Expanded) identifier